Self-management benefits asthma patients

Asthma self-management, which includes patient education, an action plan and regular review, seems to reduce hospitalisations, A&E attendances and unscheduled consultations, according to BMC Medicine.

The authors examined 27 previous systematic reviews, covering 244 randomised controlled trials (RCTs). They also included 13 RCTs published since the last search dates of the previous reviews. Based on four meta-analyses, the proportion of patients hospitalised declined from 7.2-25.9 per cent (depending on the study) to 4.6-14.0 per cent.

A&E attendances declined from 19.4-30.7 per cent to 13.1-22.4 per cent. The proportion of patients having unscheduled consultations declined from 36.6 to 24.9 per cent in one meta-analysis and from 22.0 to 14.3 per cent in the other. Reduced hospitalisations and A&E visits offset the cost of self-management support.

Self-management also seems to improve asthma control and quality of life. For example, six out of 10 reviews reported that self-management reduced symptoms.

The other four reviews examining symptom control reported inconsistent results or no benefit.

BMC Medicine DOI: 10.1186/s12916-017-0823-7

Recommended

Community pharmacies to pilot fast-track UTI service

Smoking during pregnancy numbers still high




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.